Patents by Inventor Lorena Muggetti

Lorena Muggetti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250017877
    Abstract: The present invention relates to an aqueous pharmaceutical composition for parenteral administration to a human, comprising a pharmacologically effective amount of a pharmaceutically acceptable vitamin K, a polyethoxylated castor oil as solubilizer, and a citrate buffer at a concentration of 1 to 40 mmol/L, wherein the pH of the composition is between 3.5 and 7.0, to a pharmaceutically acceptable container comprising the composition, and to the composition for use in the treatment or prevention of vitamin K deficiency and/or haemorrhage or for use as an antidote to anticoagulants of the coumarin type as well as to a method for preparing the composition.
    Type: Application
    Filed: October 20, 2022
    Publication date: January 16, 2025
    Applicant: FRESENIUS KABI AUSTRIA GMBH
    Inventors: Patricia SEGER, Theofanis MANTOURLIAS, Lorena MUGGETTI
  • Patent number: 7201913
    Abstract: The present invention relates to a semi-solid filling medium which comprises a camptothecin derivative; a pharmaceutically acceptable carrier matrix which is a polyglycolized glyceride; and an effective thickening-reducing and stabilizing-promoting amount of one or more pharmaceutically acceptable excipients.
    Type: Grant
    Filed: October 2, 2000
    Date of Patent: April 10, 2007
    Assignee: Pfizer Inc.
    Inventors: Lorena Muggetti, Alessandro Martini, Paola Civaroli, Christopher James
  • Patent number: 6730664
    Abstract: A pharmaceutical formulation which comprises a parenterally acceptable carrier or diluent, estramustine phosphate and a sulfoalkyl ether cyclodextrin. The formulation can be administered according to a combined chemotherapy regimen in association with one or more chemotherapeutic agents. The formulation also enables estramustin phosphate to be administered with no side effects at the site of injection.
    Type: Grant
    Filed: March 15, 2002
    Date of Patent: May 4, 2004
    Assignee: Pharmacia Italia S.p.A.
    Inventors: Lorena Muggetti, Paolo Colombo, Alessandro Martini, Giovanni Buzzi
  • Publication number: 20040024044
    Abstract: The present invention concerns the use of aromatase inhibitor exemestane, either alone or in combination with other therapeutic agents in the chemoprevention of estrogen dependent cancer in mammals, including humans, at increased risk of the disease.
    Type: Application
    Filed: August 4, 2003
    Publication date: February 5, 2004
    Inventors: Enrico Di Salle, Gabriella Piscitelli, Giorgio Massimini, Dinesh Purandare, Alessandro Martini, Lorena Muggetti
  • Publication number: 20040014693
    Abstract: The present invention relates to the use of arginine and, more in particular, to the injectable formulations for intravenous use comprising it, in the prevention and treatment of the side effects associated with the extravasation of drugs administered by intravenous route.
    Type: Application
    Filed: July 14, 2003
    Publication date: January 22, 2004
    Inventors: Lorena Muggetti, Alessandro Martini, Giovanni Buzzi, Paolo Colombo
  • Patent number: 6569452
    Abstract: An oral pharmaceutical formulation, which comprises, in a hydroxypropylmethylcellulose capsule, a camptothecin analogue dispersed or solubilized in a semi-solid matrix of a polyethyleneglycol with a molecular weight ranging from 400 to 20000.
    Type: Grant
    Filed: June 20, 2001
    Date of Patent: May 27, 2003
    Assignee: Pharmacia Italia S.p.A.
    Inventors: Paola Civaroli, Lorena Muggetti, Alessandro Martini
  • Patent number: 5804209
    Abstract: The present invention relates to bioadhesive starches, to a process for their preparation and to pharmaceutical compositions containing them. It also relates to the use of such bioadhesive starches as carriers for the administration of a drug.
    Type: Grant
    Filed: February 9, 1996
    Date of Patent: September 8, 1998
    Assignee: Pharmacia S.p.A.
    Inventors: Roberto De Ponti, Alessandro Martini, Lorena Muggetti
  • Patent number: 5712260
    Abstract: The present invention provides a pharmaceutical composition comprising an estramustine derivative and a cyclodextrin, particularly in the manufacture of a medicament suitable for the oral administration of an estramustine derivative to a patient suffering from a tumor.Estramustine derivatives according to the invention are, for example, compounds of general formula (I) ##STR1## wherein R is ##STR2## in which R.sub.1 is C.sub.1 -C.sub.4 alkyl and n is 0, 1 or 2, and the pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: May 6, 1996
    Date of Patent: January 27, 1998
    Assignee: Pharmacia AB
    Inventors: Alessandro Martini, Giuseppe Maccari, Lorena Muggetti, Giuseppe Colombo, Giovanni Buzzi